Terminology Service for NFDI4Health
Lapatinib/Letrozole/Trastuzumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C156307
A chemotherapy regimen consisting of lapatinib, letrozole, and trastuzumab that may be used in the treatment of premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2; HER-2; ERBB2)-positive recurrent or metastatic breast cancer. [ ]
Term info
Label
Lapatinib/Letrozole/Trastuzumab Regimen
Synonyms
- Lapatinib-Letrozole-Trastuzumab
- Lapatinib/Letrozole/Herceptin
- Lapatinib/Letrozole/Trastuzumab
- Lapatinib/Letrozole/Trastuzumab Regimen
- Letrozole/Lapatinib/Trastuzumab
- Letrozole/Lapatinib/Trastuzumab Regimen
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL563137
Preferred Name
Lapatinib/Letrozole/Trastuzumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C156307